IVL and Alzheimer disease: The expression of keratin1, filaggrin, loricrin, and involucrin significantly decreased in DNCB-induced AD-like skin lesions, which markedly improved following administration of cASCs and cASC-EVs (Figure 4C,E and Table 1).